Cherry silver berry (Elaeagnus multiflora) extracts exert antiinflammatory effects by inhibiting COX-2 and Akt signals in HT-29 colon cancer cells

Food Science and Biotechnology

Volumn 19, Issue 6, 2010, Pages 1673-1677

  Lee, Mee Sook ^a   Lee, Yun Kyoung ^a   Park, Ock Jin ^a  

^a Hannam University Daedeok Valley Campus ^*  (South Korea)

Author keywords

Akt; Apoptosis; Colon cancer; Cyclooxygenase 2; Elaeagnus multiflora

Indexed keywords

AKT; ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY EFFECTS; ANTIPROLIFERATIVE EFFECT; CANCER CELLS; CANCER GROWTH; CELL VIABILITY; COLON CANCER; COLON CANCER CELLS; CYCLOOXYGENASE 2; CYCLOOXYGENASES; ELAEAGNUS MULTIFLORA; INDUCED APOPTOSIS; NATURAL PRODUCTS; ORIENTAL MEDICINES; PREVENTIVE AGENTS;

CELL DEATH; CELL GROWTH; DISEASES; FRUITS; GROWTH KINETICS; SEED;

SILVER;

ELAEAGNUS MULTIFLORA;

EID: 79959737326     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-010-0237-1     Document Type: Article

References (23)

1. Ahmadiani A, Hosseiny J, Semnanian S, Javan M, Saeedi F, Kamalinejad M, Saremi S. Antinociceptive and anti-inflammatory effects of Elaeagnus angustifolia fruit extract. J. Ethnopharmacol. 72: 287-292 (2000)
2. Lee YS, Chang ZQ, Oh BC, Park SC, Shin SR, Kim NW. Antioxidant activity, anti-inflammatory activity, and whitening effects of extracts of Elaeagnus multiflora Thunb. J. Med. Food 10: 126-133 (2007)
3. Kim SA, Oh SI, Lee MS. Antioxidative and cytotoxic effects of solvent fractions from Elaeagnus multiflora. Korean J. Food Nutr. 2: 134-142 (2007)
4. Chang ZQ, Park SC, Oh BC, Lee YS, Shin SR, Kim NW. Antiplatelet aggregation and anti-inflammatory activity for extracts of Elaeagnus multiflora. Korean J. Med. Crop Sci. 14: 516-517 (2006)
5. Oh SI, Lee MS. Antioxidative and cytotoxic effects of ethanol extracts from Elaeagnus multiflora. Korean J. Food Nutr. 4: 403-409 (2008)
6. Breynaert C, Vermeire S, Rutgeerts P, Van Assche G. Dysplasia and colorectal cancer in inflammatory bowel disease: A result of inflammation or an intrinsic risk? Acta Gastro-Ent. Belg. 71: 367-372 (2008)
7. Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J. Gastroenterol. 14: 378-389 (2008)
8. Sinicrope FA. Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer. Mol. Carcinogen. 45: 447-454 (2006)
9. Sinicrope FA, Gill S. Role of cyclooxygenase-2 in colorectal cancer. J. Cancer Metast. Rev. 23: 63-75 (2004)
10. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: A novel target for cancer chemotherapy? J. Cancer Res. Clin. 127: 411-417 (2001)
11. Hill MM, Hemmings BA. Inhibition of protein kinase B/Akt. implications for cancer therapy. Pharmacol. Therapeut. 93: 243-251 (2002)
12. Testa JR, Bellacosa A. AKT plays a central role in tumorigenesis. P. Natl. Acad. Sci. USA 98: 10983-10985 (2001)
13. Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 8: 627-644 (2009)
14. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Tar. 8: 187-198 (2008)
15. Guha M, Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277: 32124-32132 (2002)
16. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. New Engl. J. Med. 356: 2131-2142 (2007)
17. Baron JA, Sandler RS. Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu. Rev. Med. 51: 511-523 (2000)
18. Huls G, Koornstra JJ, Kleibeuker JH. Non-steroidal antiinflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362: 230-232 (2003)
19. Kumar N, Shibata D, Helm J, Coppola D, Malafa M. Green tea polyphenols in the prevention of colon cancer. Front. Biosci. 12: 2309-2315 (2007)
20. Fournier DB, Gordon GB. COX-2 and colon cancer: Potential targets for chemoprevention. J. Cell Biochem. S34: 97-102 (2000)
21. Reddy BS. Strategies for colon cancer prevention: Combination of chemopreventive agents. Sub-Cell. Biochem. 42: 213-225 (2007)
22. Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M. The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI5K-Akt/PκB pathway. Anticancer Res. 26: 1177-1181 (2006)
23. Jiang H, Fan D, Zhou G, Li X, Deng H. Phosphatidylinositol3-kinase inhibitor (LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo. J. Exp. Clin. Canc. Res. 29: 34-40 (2010)